Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection

被引:82
|
作者
Zangerle, R [1 ]
Widner, B
Quirchmair, G
Neurauter, G
Sarcletti, M
Fuchs, D
机构
[1] Leopold Franzens Univ, Dept Dermatol & Venerol, HIV Unit, Innsbruck, Austria
[2] Leopold Franzens Univ, Inst Med Chem & Biochem, Innsbruck, Austria
[3] Ludwig Boltzmann Inst AIDS Res, Innsbruck, Austria
关键词
HIV; tryptophan; kynurenine; immune activation; neopterin;
D O I
10.1006/clim.2002.5231
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antiretroviral therapy (ART) has a significant impact on HIV-1 RNA levels, the CD4 cell count, and immune activation. We examined whether these changes are associated with a change in the rate of tryptophan degradation (expressed as the kynurenine to tryptophan ratio, kyn/trp) as an estimate for the activity of interferon-gamma inducible enzyme indoleamine (2, 3)-dioxygenase (IDO). Plasma levels of tryptophan, kynurenine, and neopterin were measured pre-therapy and 6 months postinitiation of therapy in 45 patients with HIV-1 RNA levels of less than 1000 copies/ml 6 months after initiation of ART. Before ART, the patients had decreased tryptophan and increased kynurenine concentrations compared to healthy controls. During ART, average tryptophan levels increased; in the same time kynurenine and kyn/trp decreased (P<0.001), although not to normal levels. Since pretherapy tryptophan concentrations correlated inversely with neopterin, and kynurenine correlated with viral load and neopterin but not with CD4 cell count, the data support the view that HIV production may induce immune activation and consequently tryptophan is degraded at a higher rate. In agreement, kyn/trp positively correlated with neopterin (r(s) = 0.60, P<0.001), with virus load (r(s) = 0.37, P =0.013), and very weakly with CD4(+) cells counts (r(s) = 0.30, P=0.049). The change in the kyn/trp ratio during ART correlated more strongly with the change in neopterin levels (r(s) = 0.49, P=0.001) than with the change in HIV RNA levels and weakly with the CD4 cell count. The data underscore the fact that both neopterin production and tryptophan degradation are triggered by immune activation. Tryptophan degradation is increased in HIV infection and partially reversed under ART. The data agree with the concept that immune activation is the common background of IDO activation which may be an important factor underlying T-cell hyporesponsiveness. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:242 / 247
页数:6
相关论文
共 50 条
  • [1] Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection
    Neurauter, G
    Zangerle, R
    Widner, B
    Quirchmair, G
    Sarcletti, M
    Fuchs, D
    DEVELOPMENTS IN TRYPTOPHAN AND SEROTONIN METABOLISM, 2003, 527 : 317 - 323
  • [2] Early antiretroviral therapy reduces HIV-1 DNA following perinatal HIV-1 infection
    Foster, C.
    Kaye, S.
    Fidler, S.
    Pace, M.
    Jones, M.
    Hopkins, E.
    Robinson, N.
    Frater, J.
    HIV MEDICINE, 2015, 16 : 6 - 6
  • [3] Prevention of HIV-1 Infection with Antiretroviral Therapy
    Rodger, Alison
    Phillips, Andrew
    Lundgren, Jens
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20): : 1934 - 1934
  • [4] ANTIRETROVIRAL COMBINATION THERAPY FOR HIV-1 INFECTION
    HERIDA, M
    PRESSE MEDICALE, 1995, 24 (23): : 1056 - 1058
  • [5] Coccidioidomycosis in Patients with HIV-1 Infection in the Era of Potent Antiretroviral Therapy
    Masannat, Fares Y.
    Ampel, Neil M.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) : 1 - 7
  • [6] Immunological recovery and antiretroviral therapy in HIV-1 infection
    Battegay, M
    Nuesch, R
    Hirschel, B
    Kaufmann, GR
    LANCET INFECTIOUS DISEASES, 2006, 6 (05): : 280 - 287
  • [7] A quantitative basis for antiretroviral therapy for HIV-1 infection
    Jilek, Benjamin L.
    Zarr, Melissa
    Sampah, Maame E.
    Rabi, S. Alireza
    Bullen, Cynthia K.
    Lai, Jun
    Shen, Lin
    Siliciano, Robert F.
    NATURE MEDICINE, 2012, 18 (03) : 446 - U211
  • [8] Prevention of HIV-1 Infection with Early Antiretroviral Therapy
    Cohen, Myron S.
    Chen, Ying Q.
    McCauley, Marybeth
    Gamble, Theresa
    Hosseinipour, Mina C.
    Kumarasamy, Nagalingeswaran
    Hakim, James G.
    Kumwenda, Johnstone
    Grinsztejn, Beatriz
    Pilotto, Jose H. S.
    Godbole, Sheela V.
    Mehendale, Sanjay
    Chariyalertsak, Suwat
    Santos, Breno R.
    Mayer, Kenneth H.
    Hoffman, Irving F.
    Eshleman, Susan H.
    Piwowar-Manning, Estelle
    Wang, Lei
    Makhema, Joseph
    Mills, Lisa A.
    de Bruyn, Guy
    Sanne, Ian
    Eron, Joseph
    Gallant, Joel
    Havlir, Diane
    Swindells, Susan
    Ribaudo, Heather
    Elharrar, Vanessa
    Burns, David
    Taha, Taha E.
    Nielsen-Saines, Karin
    Celentano, David
    Essex, Max
    Fleming, Thomas R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (06): : 493 - 505
  • [9] A quantitative basis for antiretroviral therapy for HIV-1 infection
    Benjamin L Jilek
    Melissa Zarr
    Maame E Sampah
    S Alireza Rabi
    Cynthia K Bullen
    Jun Lai
    Lin Shen
    Robert F Siliciano
    Nature Medicine, 2012, 18 : 446 - 451
  • [10] Information processing and antiretroviral therapy in HIV-1 infection
    Martin, EM
    Pitrak, DL
    Pursell, KJ
    Andersen, BR
    Mullane, KM
    Novak, RM
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 1998, 4 (04) : 329 - 335